Clinical Trial Update: IVIG in Acute Ischemic Stroke: A Pilot Study [Phase 1]

View source ↗

Summary

A Phase 1 pilot trial evaluating intravenous immunoglobulin (IVIG) for acute ischemic stroke was withdrawn, with status listed as withdrawn and no results repor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• IVIG (intravenous immunoglobulin)

Snippet

Sponsor: Inova Health Care Services | Conditions: Ischemic Stroke | Phase 1 | Status: WITHDRAWN